• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植后复发性原发性硬化性胆管炎:一项磁共振胆管造影研究及预测因素分析

Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.

作者信息

Brandsaeter Bjorn, Schrumpf Erik, Bentdal Oystein, Brabrand Kurt, Smith Hans Jorgen, Abildgaard Andreas, Clausen Ole Petter, Bjoro Kristian

机构信息

Department of Medicine, Rikshospitalet, Oslo, Norway.

出版信息

Liver Transpl. 2005 Nov;11(11):1361-9. doi: 10.1002/lt.20444.

DOI:10.1002/lt.20444
PMID:16184522
Abstract

Primary sclerosing cholangitis (PSC) is a well-established indication for orthotopic liver transplantation (OLT), but post-OLT bile duct strictures complicate the outcome for these patients. These strictures might represent recurrent PSC (rPSC). To estimate the risk factors for post-OLT non-anastomotic bile duct strictures in PSC patients and to find their possible etiology, we performed magnetic resonance cholangiography (MRC) and angiography (MRA) in all PSC patients who had undergone OLT and were alive (median follow-up 6.4 years, range 1.4-15.2 years). This group of PSC patients was compared to a group of 45 non-PSC patients who had also undergone OLT. A logistic regression analysis was performed to find predictors of rPSC. Bile duct strictures were found in 19/49 PSC patients and in 4/45 non-PSC patients (P = 0.001). In the PSC group nine patients without other possible explanations for bile duct strictures than rPSC were identified, i.e., the estimated risk of rPSC was 9/49 (18%); surprisingly similar changes were also seen in one patient without a pre-transplant PSC diagnosis. Severe liver disease due to rPSC was seen in 4/9 patients (one patient died and three are being evaluated for re-OLT). Steroid-resistant rejection was the only significant predictor for rPSC. In conclusion, our study shows that by the use of MRC we found more bile duct strictures in PSC patients post-OLT compared to controls and that steroid-resistant rejections was a predictor of such changes.

摘要

原发性硬化性胆管炎(PSC)是原位肝移植(OLT)公认的适应证,但OLT术后胆管狭窄会使这些患者的预后复杂化。这些狭窄可能代表复发性PSC(rPSC)。为了评估PSC患者OLT术后非吻合口胆管狭窄的危险因素并找出其可能的病因,我们对所有接受OLT且存活的PSC患者(中位随访6.4年,范围1.4 - 15.2年)进行了磁共振胆管造影(MRC)和血管造影(MRA)。将这组PSC患者与另一组同样接受OLT的45例非PSC患者进行比较。进行逻辑回归分析以找出rPSC的预测因素。在49例PSC患者中有19例发现胆管狭窄,在45例非PSC患者中有4例发现胆管狭窄(P = 0.001)。在PSC组中,有9例患者除rPSC外没有其他可能导致胆管狭窄的原因,即rPSC的估计风险为9/49(18%);令人惊讶的是,在1例移植前未诊断为PSC的患者中也观察到了类似变化。9例患者中有4例因rPSC出现严重肝病(1例患者死亡,3例正在评估再次OLT)。激素抵抗性排斥是rPSC唯一的显著预测因素。总之,我们的研究表明,通过使用MRC,我们发现与对照组相比,PSC患者OLT术后胆管狭窄更多,且激素抵抗性排斥是此类变化的一个预测因素。

相似文献

1
Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.肝移植后复发性原发性硬化性胆管炎:一项磁共振胆管造影研究及预测因素分析
Liver Transpl. 2005 Nov;11(11):1361-9. doi: 10.1002/lt.20444.
2
Recurrence of primary sclerosing cholangitis after liver transplantation.肝移植后原发性硬化性胆管炎的复发
Liver Transpl. 2002 Jul;8(7):575-81. doi: 10.1053/jlts.2002.33952.
3
Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients.原发性硬化性胆管炎在小儿肝移植受者中的复发。
Liver Transpl. 2014 Jun;20(6):679-86. doi: 10.1002/lt.23868.
4
Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.原发性硬化性胆管炎的原位肝移植:单中心12年经验
Ann Surg. 1997 May;225(5):472-81; discussion 481-3. doi: 10.1097/00000658-199705000-00004.
5
Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with inflammatory bowel disease.原发性硬化性胆管炎肝移植后复发的风险与炎症性肠病有关。
World J Gastroenterol. 2018 Nov 21;24(43):4939-4949. doi: 10.3748/wjg.v24.i43.4939.
6
A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.肝移植中原发性硬化性胆管炎复发危险因素的重新评估。
Liver Transpl. 2009 Mar;15(3):330-40. doi: 10.1002/lt.21679.
7
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.肝移植后原发性硬化性胆管炎复发的危险因素。
Liver Transpl. 2008 Feb;14(2):138-43. doi: 10.1002/lt.21260.
8
Duct-to-duct reconstruction in liver transplantation for primary sclerosing cholangitis is associated with fewer biliary complications in comparison with hepaticojejunostomy.与肝空肠吻合术相比,原发性硬化性胆管炎肝移植中的胆管对胆管重建与更少的胆道并发症相关。
Liver Transpl. 2014 Apr;20(4):457-63. doi: 10.1002/lt.23827.
9
Risk factors for recurrent primary sclerosing cholangitis after liver transplantation.肝移植后原发性硬化性胆管炎复发的危险因素。
J Hepatol. 2015 Nov;63(5):1139-46. doi: 10.1016/j.jhep.2015.07.005. Epub 2015 Jul 14.
10
Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation.肝移植后原发性硬化性胆管炎复发的危险因素。
Liver Transpl. 2008 Feb;14(2):245-51. doi: 10.1002/lt.21394.

引用本文的文献

1
Recurrence of Primary Disease After Adult Liver Transplant - Risk Factors, Early Diagnosis, Management, and Prevention.成人肝移植后原发性疾病的复发——危险因素、早期诊断、管理及预防
J Clin Exp Hepatol. 2024 Nov-Dec;14(6):101432. doi: 10.1016/j.jceh.2024.101432. Epub 2024 May 22.
2
Detrimental impact of early biopsy-proven rejection in liver transplantation.肝移植中早期经活检证实排斥反应的不良影响。
Clin Transplant. 2024 Jan;38(1):e15206. doi: 10.1111/ctr.15206. Epub 2023 Dec 1.
3
Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence.
移植后管理及自身免疫性肝炎、原发性胆汁性胆管炎和原发性硬化性胆管炎的并发症,包括疾病复发。
Clin Liver Dis. 2024 Feb;28(1):193-207. doi: 10.1016/j.cld.2023.07.009. Epub 2023 Aug 26.
4
The differences in post-liver transplant outcomes of patients with autoimmune hepatitis who present with overlapping autoimmune liver diseases.伴有重叠性自身免疫性肝病的自身免疫性肝炎患者肝移植术后结局的差异。
Hepatol Int. 2023 Jun;17(3):720-734. doi: 10.1007/s12072-022-10468-8. Epub 2022 Dec 27.
5
Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation.系统评价与荟萃分析:肝移植后原发性硬化性胆管炎复发的危险因素。
Aliment Pharmacol Ther. 2019 Mar;49(6):636-643. doi: 10.1111/apt.15148. Epub 2019 Feb 10.
6
Risk of recurrence of primary sclerosing cholangitis after liver transplantation is associated with inflammatory bowel disease.原发性硬化性胆管炎肝移植后复发的风险与炎症性肠病有关。
World J Gastroenterol. 2018 Nov 21;24(43):4939-4949. doi: 10.3748/wjg.v24.i43.4939.
7
Post-Transplant Disease Recurrence in Pediatric PSC.儿童原发性硬化性胆管炎移植后疾病复发
Curr Gastroenterol Rep. 2018 Aug 6;20(9):44. doi: 10.1007/s11894-018-0649-2.
8
Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid.使用无皮质类固醇的长期双重免疫抑制方案的自身免疫性肝病肝移植受者的结局
Transplant Direct. 2017 Jun 23;3(7):e178. doi: 10.1097/TXD.0000000000000693. eCollection 2017 Jul.
9
Recurrence of autoimmune liver diseases after liver transplantation.肝移植后自身免疫性肝病的复发
World J Hepatol. 2015 Dec 18;7(29):2896-905. doi: 10.4254/wjh.v7.i29.2896.
10
Autoimmune Liver Disease Post-Liver Transplantation: A Summary and Proposed Areas for Future Research.肝移植后自身免疫性肝病:总结与未来研究的建议领域
Transplantation. 2016 Mar;100(3):515-24. doi: 10.1097/TP.0000000000000922.